ACER Acer Therapeutics Inc.

19.78
-2.93  -13%
Previous Close 22.71
Open 22.98
Price To Book 4.42
Market Cap 199528040
Shares 10,087,363
Volume 101,148
Short Ratio
Av. Daily Volume 39,036

NewsSee all news

  1. Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data
  2. Introducing Acer Therapeutics (NASDAQ:ACER), A Stock That Climbed 27% In The Last Year
  3. Acer Therapeutics to Participate in Upcoming Investor Conferences
  4. Acer Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
  5. Acer Therapeutics Announces In-license of Osanetant from Sanofi

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

PDUFA date under priority review June 25, 2019.
EDSIVO
Vascular Ehlers-Danlos Syndrome
Phase 2b trial did not meet primary endpoint - October 28, 2016.
Tovaxin (Tcelna)
Secondary Progressive MS (SPMS)
NDA filing planned for 2019.
ACER-001
Urea cycle disorder (UCD)

Latest News

  1. Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data
  2. Introducing Acer Therapeutics (NASDAQ:ACER), A Stock That Climbed 27% In The Last Year
  3. Acer Therapeutics to Participate in Upcoming Investor Conferences
  4. Acer Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
  5. Acer Therapeutics Announces In-license of Osanetant from Sanofi
  6. Is This Biotech Stock Turning A Corner? Acer Pops On FDA Acceptance
  7. Acer Therapeutics Announces FDA Acceptance of NDA and Priority Review for EDSIVO™ for the Treatment of vEDS
  8. Opexa Therapeutics Enters Oversold Territory
  9. Acer Therapeutics Appoints Salma Jutt as Chief Commercial Officer
  10. Acer Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
  11. Acer Therapeutics to Present at the Evercore ISI HealthConX Conference
  12. Do Institutions Own Shares In Acer Therapeutics Inc (NASDAQ:ACER)?